Universal Ibogaine provides update on status of current Cease Trade Order
Calgary, AB – February 5, 2025 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, provides the following update related to the previously issued Management Cease Trade Order (“MCTO”). As was noted in the Company’s prior news releases (last dated January 27, 2025), UI was not in [...]